Evidence map›Paper›PMID 31198431›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2019

Medicinal Properties and Active Constituents of

Parisa Heydari, Maryam Yavari, Peyman Adibi, Gholamreza Asghari, Syed-Mustafa Ghanadian, Gabriel O Dida, Faham Khamesipour

Erratum issuedOpen access · hybridAbstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
11.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 54 citations in OpenAlex.

  1. Phytochemical Diversity and Antioxidant Potential ofAntioxidants (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. A Comprehensive Review of the Phenolic Compounds inMolecules (Basel, Switzerland) · 2025
    Review
  6. Luteolin-Rich Fraction fromInternational journal of preventive medicine · 2025
    Article
  7. Heliyon · 2024
    Article
  8. Pharmacophylogenetic relationships of genusFrontiers in pharmacology · 2024
    Review
  9. Article
  10. Metabolites · 2023
    Article
  11. Article
  12. Drawbacks for Studies on the Essential Oil ofThe Malaysian journal of medical sciences : MJMS · 2023
    Article
  13. A double-blind randomized clinical trial ofResearch in pharmaceutical sciences · 2023
    Article
  14. Review
  15. Induction of apoptosis by hydroalcoholic and methanolic extract ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. BioMed research international · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Parisa HeydariDepartment of Persian Medicine, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Maryam YavariDepartment of Persian Medicine, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Peyman AdibiIntegrative Functional Gastroenterology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID 0000-0003-3247-4828
Gholamreza AsghariDepartment of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Syed-Mustafa GhanadianDepartment of Pharmacognosy, Faculty of Pharmacy, Isfahan University of Medical Sciences, Isfahan, Iran.
Gabriel O DidaSchool of Public Health and Community Development, Maseno University, Kenya.
Faham KhamesipourCellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.ORCID 0000-0003-0678-2528
Isfahan University of Medical Sciences · IRSabzevar University of Medical Sciences · IRTechnical University of Kenya · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectives

methodsThe Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used in the search for published articles on medicinal properties and active ingredients of

resultsA total of 1158 scientific articles were sourced from the various databases, out of which 38 met the search criteria and qualified for this review. The studies were conducted in only 9 of the 31 provinces of Iran, with a large proportion in Isfahan province, central Iran. The studies showed that all plant parts (roots, aerial parts, flowers, and leaves) had active constituents. Essential oils and aerial plant parts were the main components studied. Nevertheless, the most frequently reported constituents were xanthomicrol, limonene, luteolin, geranial, apigenin, and calycopterin. A number of medicinal properties were reported among them antioxidant, antibacterial, anticancerous, antinociceptive, antihyperlipidemic, antispasmodic, cytotoxic, and immunomodulatory effects. The plant was also reported to be a remedy for inflammatory pain, headaches, congestion, liver disorders, ulcer, fever, renal pain, dyspepsia, stomach ache, abdominal pain, joints pains, muscle spasm, congestion, bloating, and wound healing effects, among others.

conclusionThis review has shown that

Identifiers

PMID31198431
PMCPMC6526565
OpenAlexW2943382945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.